Cogent Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cogent Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2018 to Q3 2024.
  • Cogent Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 110M shares, a 27.9% increase year-over-year.
  • Cogent Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79.7M shares, a 35.6% increase from 2022.
  • Cogent Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 58.7M shares, a 51.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 110M +24M +27.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 99.2M +24.5M +32.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 94.8M +24.1M +34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 79.7M +20.9M +35.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 86.2M +16.6M +23.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 74.8M +25.4M +51.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 70.7M +25.6M +56.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 58.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 69.6M +29.7M +74.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 49.4M +10.9M +28.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 45.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 39.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 38.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q4 2019 30.7B +645M +2.15% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-26
Q3 2019 30.7B +782M +2.62% Jul 1, 2019 Sep 30, 2019 10-K 2020-03-26
Q2 2019 30.5B +1.35B +4.63% Apr 1, 2019 Jun 30, 2019 10-K 2020-03-26
Q1 2019 30.1B +19.9B +195% Jan 1, 2019 Mar 31, 2019 10-K 2020-03-26
Q4 2018 30B Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 29.9B Jul 1, 2018 Sep 30, 2018 10-K 2020-03-26
Q2 2018 29.2B Apr 1, 2018 Jun 30, 2018 10-K 2020-03-26
Q1 2018 10.2B Jan 1, 2018 Mar 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.